Zelanna Goldberg
Directeur Technique/Scientifique/R&D chez Replicate Bioscience, Inc.
Profil
Zelanna Goldberg is currently the Chief Medical Officer at Replicate Bioscience, Inc. She previously worked as an Associate Professor in the Radiation Oncology Department at Davis Medical Center and as the Senior Vice President of Clinical Sciences at Iovance Biotherapeutics, Inc. In 2021, she briefly served as the Chief Medical Officer at Alpine Immune Sciences, Inc. Goldberg holds a graduate degree from the University of California San Diego and a doctorate from the University of Toronto Faculty of Medicine.
Postes actifs de Zelanna Goldberg
| Sociétés | Poste | Début |
|---|---|---|
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Directeur Technique/Scientifique/R&D | 12/07/2022 |
Anciens postes connus de Zelanna Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 08/10/2021 |
Davis Medical Center
 Davis Medical Center Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Davis Medical Center is a 149-bed acute care hospital. The company is based in Statesville, NC. Davis Medical Center was acquired by Health Management Associates, Inc., part of Community Health Systems, Inc. from January 27, 2014 on October 02, 2000. | Corporate Officer/Principal | - |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Zelanna Goldberg
| University of Toronto Faculty of Medicine | Doctorate Degree |
| University of California San Diego | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Davis Medical Center
Davis Medical Center Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Davis Medical Center is a 149-bed acute care hospital. The company is based in Statesville, NC. Davis Medical Center was acquired by Health Management Associates, Inc., part of Community Health Systems, Inc. from January 27, 2014 on October 02, 2000. | Health Services |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Commercial Services |